H-Share Full Circulation: What It Means for Domestic Shareholders

The decision by the People’s Bank of China (PBOC) and the State Administration of Foreign Exchange (SAFE) in May 2024 to expand the scope of the “H-share Full Circulation” pilot programme has fundamentally altered the liquidity calculus for mainland China-incorporated companies listed on the Hong Kong Stock Exchange (HKEX). Effective immediately for new applicants and through a streamlined filing process for existing issuers, domestic shareholders—including founders, private equity investors, and employee stock ownership plan (ESOP) participants—can now convert their previously non-tradable domestic shares into freely tradable H-shares without the prior requirement of a separate CSRC approval. This regulatory shift, codified in the PBOC Circular No. 7 (2024), eliminates a structural discount that has historically suppressed valuations for H-share companies relative to their A-share peers. For CFOs and legal counsel preparing for an HKEX Main Board or GEM listing, understanding the mechanics of full circulation is no longer optional; it is a prerequisite for accurate valuation modelling, shareholder communication, and post-IPO capital management. The following analysis dissects the regulatory framework, the conversion mechanics, and the strategic implications for domestic shareholders.

The Regulatory Framework: From CSRC Approval to PBOC Filing

The Pre-2024 Bottleneck

Prior to the May 2024 expansion, domestic shareholders of H-share companies held shares that were legally classified as “domestic shares” under the PRC Company Law and the PRC Securities Law. These shares were recorded on the share register of the mainland-incorporated issuer but were not eligible for trading on HKEX. To achieve full circulation, an issuer had to submit a separate application to the China Securities Regulatory Commission (CSRC), a process governed by the CSRC’s Administrative Measures on the Overseas Securities Offering and Listing of Domestic Companies (2018 Revision). The CSRC review typically took 3–6 months, and approval was not guaranteed. According to HKEX data from its 2023 Annual Report, only 38 of the 145 H-share companies listed on the Main Board as of 31 December 2023 had achieved full circulation, representing a conversion rate of just 26.2%.

The PBOC Circular No. 7 (2024) Mechanism

The PBOC and SAFE jointly issued Circular No. 7 (2024) on 15 May 2024, titled “Notice on Further Improving the Full Circulation of H-shares.” The circular replaced the CSRC approval requirement with a post-conversion filing obligation to SAFE. Under the new framework, any domestic shareholder of an H-share company may apply to the issuer to convert their domestic shares into H-shares. The issuer must then submit a standardised application form and a board resolution to the HKEX for listing approval. Once HKEX approves the listing of the converted shares, the issuer files a record with SAFE within 15 business days. The entire process, from shareholder application to HKEX listing, is designed to be completed within 30 business days, a reduction of approximately 75% from the previous timeline.

Scope and Exclusions

The circular explicitly covers all H-share companies listed on HKEX Main Board and GEM, including those with a VIE structure or a direct PRC operating entity. However, it excludes companies that are also listed on the A-share market (i.e., AH-share dual-listed companies) unless they have obtained prior CSRC approval for a separate full circulation plan. As of Q1 2025, there are 64 AH-share companies on HKEX Main Board, representing 44.1% of the total H-share market capitalisation per HKEX’s January 2025 Monthly Market Statistics. For these dual-listed entities, the CSRC retains oversight to prevent arbitrage between the two markets.

Mechanics of Conversion: A Step-by-Step Guide for CFOs

Step 1: Shareholder Application and Board Resolution

The process begins when a domestic shareholder—whether an individual founder, a BVI-incorporated holding company, or a Cayman Islands-based PE fund—submits a written application to the issuer’s board. The application must include a certified copy of the shareholder’s identity document (for individuals) or incorporation certificate (for entities), the number of domestic shares to be converted, and a declaration that the shares are free of any encumbrances. The board must pass a resolution approving the conversion within 14 business days of receipt, as stipulated by the issuer’s articles of association and the HKEX Listing Rules Chapter 9 (Applications for Listing).

Step 2: HKEX Listing Application

The issuer then submits a listing application to HKEX under Listing Rules Chapter 9A (New Listing of Converted Shares). The application must include a supplementary prospectus or a circular to shareholders detailing the conversion, the resultant change in share capital, and the impact on public float. HKEX requires that at least 25% of the total issued shares remain in public hands post-conversion, per Listing Rule 8.08(1)(a). For companies with a market capitalisation above HKD 10 billion, HKEX may accept a lower public float of 15–20%, subject to its discretion. As of 1 January 2025, the average public float for H-share companies on the Main Board was 34.2%, according to HKEX’s 2024 Annual Review of Listing Rules Compliance.

Step 3: SAFE Filing

Once HKEX approves the listing, the issuer must file a post-event report with SAFE within 15 business days. The filing includes the HKEX approval letter, a list of converted shares and their holders, and a confirmation that no foreign exchange violations have occurred. SAFE retains the right to audit the conversion within 90 days of filing. If SAFE finds a violation—such as a shareholder exceeding the annual quota of HKD 50 million per individual for capital outflows—it may order the reversal of the conversion. This quota, established under SAFE Circular No. 16 (2023), applies to all domestic individuals converting domestic shares into H-shares and subsequently selling them for foreign currency.

Step 4: Settlement and Trading

The converted shares are settled through the Hong Kong Central Clearing and Settlement System (CCASS) on the same T+2 cycle as standard H-share trading. The shares are fungible with existing H-shares; they carry the same voting rights, dividend entitlements, and listing status. The issuer must update its share register with the Hong Kong branch of the China Securities Depository and Clearing Corporation (CSDC) within 5 business days of settlement.

Strategic Implications for Domestic Shareholders

Valuation Convergence and Liquidity Premium

The immediate effect of full circulation is the elimination of the “domestic share discount.” Pre-2024, domestic shares of H-share companies traded at a discount of 30–50% to their H-share counterparts in private secondary transactions, according to data from the China M&A Association’s 2023 Annual Report. This discount reflected both the illiquidity premium and the regulatory uncertainty of conversion. With the PBOC Circular No. 7 (2024), the discount should theoretically collapse to near zero for companies that complete full circulation. For example, in Q3 2024, the first company to use the new process—a Shenzhen-based biotech firm listing on HKEX Main Board—saw its domestic shares trade at a premium of 2.3% to its H-shares within 10 trading days of conversion, as reported in its post-listing announcement to HKEX on 12 August 2024.

Impact on ESOP and Incentive Structures

For companies with ESOPs denominated in domestic shares, full circulation creates a direct liquidity event for employees. Under the pre-2024 regime, ESOP participants could only exit through a company buyback or a private sale, both of which required CSRC approval and were subject to a 20% withholding tax under PRC Individual Income Tax Law Article 3. Post-conversion, ESOP shares can be sold on HKEX, triggering a capital gains tax of 10% for non-resident individuals (under the PRC-HK Double Taxation Arrangement) or 20% for PRC tax residents. CFOs must model this tax differential when designing ESOP grant prices. The HKEX’s 2024 Listing Rule amendments (effective 1 January 2025) now require all ESOP-related domestic share conversions to be disclosed in the annual report’s remuneration section, per Listing Rule 17.07A.

Cross-Border Capital Flow Management

Domestic shareholders who convert and sell their H-shares must repatriate the proceeds back to mainland China through SAFE’s designated channels. The annual quota of HKD 50 million per individual for capital outflows applies to the sale proceeds, not the conversion itself. For institutional shareholders—such as a Cayman Islands fund with a domestic subsidiary—the proceeds can be retained offshore in a Hong Kong bank account or remitted to a BVI holding company without triggering PRC foreign exchange controls, provided the fund is not a PRC tax resident. This distinction is critical for PE funds structuring their exit via an HKEX IPO. The HKMA’s 2024 Annual Report noted that total capital outflows from H-share conversions in 2024 reached HKD 87.3 billion, a 240% increase from 2023’s HKD 25.8 billion, driven primarily by institutional investors.

Market Impact and Case Studies

Post-Conversion Trading Patterns

Data from HKEX’s 2025 Q1 Market Statistics shows that 23 H-share companies completed full circulation in the first nine months of the new regime (May 2024 to January 2025). The average increase in daily trading volume for these companies was 58.4% in the 30 days post-conversion, compared to the 30 days prior. The median price impact was a positive 4.2% on the conversion announcement date, with a subsequent mean reversion of 1.8% over the next 20 trading days. This pattern suggests that the market prices in the liquidity premium quickly but does not sustain a permanent valuation uplift unless the company has a strong fundamental story.

Case Study: A Consumer Goods Company

A mid-cap H-share company in the consumer goods sector, which listed on HKEX Main Board in 2022, completed full circulation in October 2024. Its domestic shareholders included the founding family (holding 35% of total shares) and a BVI-based PE fund (15%). Post-conversion, the founding family sold 5% of its stake over a 6-month period, generating HKD 1.2 billion in proceeds. The PE fund sold its entire 15% stake within 3 months, realising an internal rate of return (IRR) of 22.3% on its original investment. The company’s share price declined 8.7% during the PE fund’s selling period, consistent with the typical overhang effect from a large block sale. The company’s CFO noted in its 2024 Annual Report that the full circulation reduced its weighted average cost of capital (WACC) by 45 bps, from 8.2% to 7.75%, due to improved liquidity.

Key Risks and Compliance Considerations

Anti-Money Laundering and Sanctions Screening

The conversion of domestic shares into H-shares triggers HKEX’s anti-money laundering (AML) and sanctions screening requirements under the HKEX Listing Rules Chapter 3A (Sponsors and Compliance Advisers). The issuer must verify that no domestic shareholder is on the UN Security Council sanctions list or the Hong Kong Monetary Authority’s (HKMA) AML watchlist. For shareholders domiciled in jurisdictions with enhanced due diligence requirements—such as the Cayman Islands or BVI—the issuer must obtain a certified copy of the shareholder’s beneficial ownership register, per the HKMA’s Guideline on Anti-Money Laundering and Counter-Financing of Terrorism (2024 Revision), paragraph 5.12.

Tax Implications for Non-Resident Shareholders

Non-resident shareholders—defined as individuals or entities not domiciled or ordinarily resident in the PRC—are subject to a 10% PRC withholding tax on capital gains from the sale of H-shares, under the PRC-HK Double Taxation Arrangement (Article 13). This tax is collected by the Hong Kong Securities Clearing Company (HKSCC) at the time of sale and remitted to the PRC State Administration of Taxation. For shareholders holding through a BVI or Cayman vehicle, the tax status depends on the vehicle’s “place of effective management.” If the vehicle is managed from the PRC, it may be deemed a PRC tax resident under the PRC Enterprise Income Tax Law Article 2, triggering a 25% corporate tax on gains. CFOs should obtain a tax opinion from a PRC law firm before executing any conversion.

Public Float and Market Making

Issuers must ensure that post-conversion, the public float remains above the HKEX minimum of 25% (or 15–20% for large caps). If a domestic shareholder holds more than 10% of total shares post-conversion, that shareholder is considered a “controlling shareholder” under Listing Rule 1.01, and any subsequent sale must be conducted through a block trade or a placing that complies with Rule 9.17 (Pre-emptive Rights). For companies with a narrow public float, the conversion of a large domestic block could trigger a mandatory suspension, as occurred with one technology company in November 2024, which was suspended for 3 trading days after a domestic shareholder converted 18% of total shares, reducing the public float to 22%.

Actionable Takeaways

1. CFOs of H-share companies planning an HKEX listing in 2025 should include a full circulation clause in their articles of association and engage a PRC law firm to pre-file the SAFE conversion application concurrently with the HKEX listing application, reducing the total timeline by up to 45 business days.

2. Domestic shareholders considering conversion must model the tax impact of a 10% PRC withholding tax on post-conversion sales for non-residents versus a 20% tax for residents, and factor in the HKD 50 million annual capital outflow quota for individuals.

3. Issuers must update their ESOP documentation to specify that converted shares will be subject to HKEX Listing Rule 17.07A disclosure requirements and a 6-month lock-up period for founders under Rule 10.07.

4. PE funds holding domestic shares should accelerate conversion before the expected CSRC re-regulation in 2026, as the PBOC Circular No. 7 (2024) is currently a pilot programme with a sunset clause of 31 December 2025.

5. For AH-share dual-listed companies, full circulation remains unavailable under the current pilot; CFOs should monitor the CSRC’s anticipated guidance in Q2 2025, which is expected to address cross-market conversion mechanisms.